Jeffrey Aronson
Jeffrey Aronson | |
|---|---|
| Born | Jeffrey Kenneth Aronson 1947 (age 76–77) |
| Nationality | United Kingdom |
Jeffrey Kenneth AronsonFRCP,HonFBPhS,HonFFPM(born 1947) is a British physician andclinical pharmacologist,currently working in theCentre for Evidence Based Medicinein Oxford.
Education
[edit]Aronson studied at theUniversity of Glasgowfrom 1964 to 1970, qualifying with the degree of MBChB, and after primary medical training in Glasgow hospitals (MRCP 1973) joined theMedical Research Council's Unit and University Department of Clinical Pharmacology in Oxford, qualifying DPhil Oxon in 1977.[1]
Career
[edit]After further clinical and scientific training, in 1980 he became Wellcome Lecturer and Consultant in Clinical Pharmacology and later Reader in Clinical Pharmacology at theUniversity of Oxfordand an honorary consultant physician in theOxford Radcliffe Hospitals Trustuntil 2014.[1]He now works as an Honorary Consultant Physician and Clinical Pharmacologist in the Centre for Evidence Based Medicine in the Nuffield Department of Primary Care Health Sciences in Oxford.
He served as president of theBritish Pharmacological Societyin 2008-2009; as vice-chairman of the Medicines Commission from 2002 to 2005; and as editor-in-chief of theBritish Journal of Clinical Pharmacologyfrom 2002 to 2007.[1]He also served as chair of theBritish Pharmacopoeia Commission's Expert Advisory Group on Nomenclature from 2006 to 2021 and currently chairs its successor committee, the Joint Expert Advisory Groups on Pharmacy and Nomenclature. He is a member of the World Health Organization’s Expert Advisory Panel on International Pharmacopoeia and Pharmaceutical Preparations. He was a member of the Formulary Committees of theBritish National Formularyfrom 2006 to 2012, and of theBritish National Formulary for Childrenfrom 2003 to 2012[1]
He was elected aFellow of the Royal College of Physiciansin 1985, an HonoraryFellow of the Faculty of Pharmaceutical Medicinein 2007, and an HonoraryFellow of the British Pharmacological Societyin 2014.[1]
He served asOxford University Assessorduring 1989-90.
Publications
[edit]He has published over 200 original scientific papers and over 300 reviews and editorial reviews in peer-reviewed bioscience journals. He publishes a weekly opinion column in the BMJ under the general heading "When I Use a Word". Starting in 1997, he edited volumes 20-35 of theSide Effects of Drugs Annual.He edited the 15th and 16th editions (Elsevier, 2006 and 2016) ofMeyler’s Side Effects of Drugs—The International Encyclopedia of Adverse Drug Reactions and Interactions.Together with John Talbot, he edited the 6th edition ofStephens’ Detection and Evaluation of Adverse Drug Reactions: Principles and Practice(Wiley-Blackwell, 2011), and, with Paul Glasziou and Les Irwig,Evidence-based Medical Monitoring: From Principles to Practice(Blackwell Publishing/BMJ Books, 2008).
- ^abcdeLois Reynolds;Tilli Tansey,eds. (2008).Clinical Pharmacology in the UK, c. 1950-2000: Industry and Regulation.Wellcome Witnesses to Contemporary Medicine.History of Modern Biomedicine Research Group.ISBN978-0-85484-118-9.OL27024689M.WikidataQ29581760.
External links
[edit]
| International | |
|---|---|
| National | |
| Academics | |
| Other | |
 | This article about a biologist from the United Kingdom is astub.You can help Wikipedia byexpanding it. |